Download the report now
Drug claims and
utilization data for:
Partner
Third-party payors
Download the report now
Read the full report
Read the full report
Biologics and biosimilars
Non-specialty drugs
Cost concentration
Cost
management
Contact us to learn more
Contact us to learn more
Our offices
Hover for contact information
Windsor
1.844.422.4260
Québec City
1.844.201.1012
Toronto
1.844.201.1012
Contact us to learn more
email: info@greenshield.ca
email: info@greenshield.ca
2021
Representing
Trend insights
Hover over each icon
1.2 million
Annual drug spend
$917 million
+
Drug Trends & strategic insights
+
In 2020 over 10,600 claimants utilized a specialty drug product
for the treatment of their condition.
Specialty drugs
Total drug cost for biosimilars reached $10.3 million, which represents an increase of 34.2% from the previous year.
GSC is seeing a growing utilization of biologic drugs to treat relatively common conditions.
Top 5% of claimants are responsible
for 51.8% of overall drug costs.
insurers
Hover over each box
A focus on tangible solutions
Emerging & future trends
• Digital pharmacy
• Mental health
• Drug pipeline
Emerging & future trends
• Biosimilar strategies
• PPNs
• PLAs
Cost
management
Claimants
Top 5% of claimants are responsible
for 51.8% of overall drug costs.
